Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3, after its cobolimab candidate flunked a phase 3 trial in lung cancer.

FIFA Medical Assessment and Research Centre, and Schulthess Clinic, Zürich, Switzerland Correspondence to Mario Bizzini, FIFA Medical Assessment and Research Centre, FIFA-Strasse 20, P.O. Box, 8044 ...

1. The Illuminati were founded in 1776 by a disgruntled scholar. He was a 28-year-old called Adam Weishaupt, a professor at the University of Ingolstadt in Bavaria. This era was a high point of the ...